Winger G, Woods J H
Department of Pharmacology, University of Michigan, 1501 W. Medical Center Drive, Ann Arbor, MI 48109, USA.
Drug Alcohol Depend. 2001 May 1;62(3):181-9. doi: 10.1016/s0376-8716(00)00166-6.
The reinforcing effects of intravenously delivered cocaine, alfentanil, morphine, heroin, nalbuphine, or buprenorphine were evaluated in four rhesus monkeys before, during, and after daily administration of 3.2 mg/kg morphine. Morphine was given 21 h prior to measures of the reinforcing effects of each of the drugs. No changes in the potency of cocaine or the high efficacy mu agonist alfentanil were detectable during the period of chronic morphine administration. Small (1/2-1) log unit decreases in the reinforcing potency of intermediate efficacy mu agonists morphine and heroin occurred during chronic morphine administration. Larger decreases in both the potency and effectiveness of low-efficacy mu agonists nalbuphine and buprenorphine developed during this time. These data suggest that the amount of tolerance that develops to the reinforcing effects of opioids depends on the efficacy of the drugs used to maintain responding.
在四只恒河猴中,于每日给予3.2mg/kg吗啡之前、期间及之后,评估静脉注射可卡因、阿芬太尼、吗啡、海洛因、纳布啡或丁丙诺啡的强化作用。在测量每种药物的强化作用前21小时给予吗啡。在慢性吗啡给药期间,未检测到可卡因或高效能μ激动剂阿芬太尼的效能发生变化。在慢性吗啡给药期间,中效能μ激动剂吗啡和海洛因的强化效能出现小幅度(1/2 - 1)对数单位的降低。在此期间,低效能μ激动剂纳布啡和丁丙诺啡的效能和有效性均出现更大幅度的降低。这些数据表明,对阿片类药物强化作用产生的耐受量取决于用于维持反应的药物的效能。